Efficacious and clinically relevant conditioned medium of human adipose-derived stem cells for therapeutic angiogenesis

Molecular Therapy

Volumn 22, Issue 4, 2014, Pages 862-872

  Bhang, Suk Ho ^a   Lee, Seahyoung ^a   Shin, Jung Youn ^a   Lee, Tae Jin ^b   Jang, Hyeon Ki ^b   Kim, Byung Soo ^a  

^a Seoul National University   (South Korea)

^b Hanyang University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; FIBROBLAST GROWTH FACTOR 2; SCATTER FACTOR; STROMAL CELL DERIVED FACTOR 1; VASCULOTROPIN; CULTURE MEDIUM;

ADIPOSE DERIVED STEM CELL; AMINO ACID BLOOD LEVEL; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CAPILLARY DENSITY; CELL GROWTH; CELL HOMING; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; GLUCOSE BLOOD LEVEL; HINDLIMB; HUMAN; HUMAN CELL; LIMB ISCHEMIA; LIMB SALVAGE; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; SPHEROID CELL; STEM CELL MOBILIZATION; ADIPOSE TISSUE; ANIMAL; APOPTOSIS; CULTURE MEDIUM; CULTURE TECHNIQUE; CYTOLOGY; GENETICS; STEM CELL;

MUS;

ADIPOSE TISSUE; ANIMALS; APOPTOSIS; CELL CULTURE TECHNIQUES; CULTURE MEDIA, CONDITIONED; HUMANS; MICE; STEM CELLS;

EID: 84897576748     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2013.301     Document Type: Article

References (33)

1. Meyer, GP, Wollert, KC, Lotz, J, Steffens, J, Lippolt, P, Fichtner, S et al. (2008). Intracoronary bone marrow cell transfer after myocardial infarction: 5-year follow-up of the BOOST trial. Circulation 118: S764-S765
2. Tateishi-Yuyama, E, Matsubara, H, Murohara, T, Ikeda, U, Shintani, S, Masaki, H et al.; Therapeutic Angiogenesis using Cell Transplantation (TACT) Study Investigators. (2002). Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: A pilot study and a randomised controlled trial. Lancet 360: 427-435
3. Menasché, P (2005). Stem cells for clinical use in cardiovascular medicine: Current limitations and future perspectives. Thromb Haemost 94: 697-701
4. Zhang, M, Methot, D, Poppa, V, Fujio, Y, Walsh, K and Murry, CE (2001). Cardiomyocyte grafting for cardiac repair: Graft cell death and anti-death strategies. J Mol Cell Cardiol 33: 907-921
5. Gallagher, G and Forrest, DL (2007). Second solid cancers after allogeneic hematopoietic stem cell transplantation. Cancer 109: 84-92
6. Friedman, DL, Leisenring, W, Schwartz, JL and Deeg, HJ (2004). Second malignant neoplasms following hematopoietic stem cell transplantation. Int J Hematol 79: 229-234
7. Kawamoto, A, Tkebuchava, T, Yamaguchi, J, Nishimura, H, Yoon, YS, Milliken, C et al. (2003). Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia. Circulation 107: 461-468
8. Barcelos, LS, Duplaa, C, Kränkel, N, Graiani, G, Invernici, G, Katare, R et al. (2009). Human CD133+ progenitor cells promote the healing of diabetic ischemic ulcers by paracrine stimulation of angiogenesis and activation of Wnt signaling. Circ Res 104: 1095-1102
9. Kinnaird, T, Stabile, E, Burnett, MS, Lee, CW, Barr, S, Fuchs, S et al. (2004). Marrowderived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res 94: 678-685
10. Angoulvant, D, Ivanes, F, Ferrera, R, Matthews, PG, Nataf, S and Ovize, M (2011). Mesenchymal stem cell conditioned media attenuates in vitro and ex vivo myocardial reperfusion injury. J Heart Lung Transplant 30: 95-102
11. Silva, EA and Mooney, DJ (2007). Spatiotemporal control of vascular endothelial growth factor delivery from injectable hydrogels enhances angiogenesis. J Thromb Haemost 5: 590-598
12. Yuen, WW, Du, NR, Chan, CH, Silva, EA and Mooney, DJ (2010). Mimicking nature by codelivery of stimulant and inhibitor to create temporally stable and spatially restricted angiogenic zones. Proc Natl Acad Sci U S A 107: 17933-17938
13. Ii, M, Horii, M, Yokoyama, A, Shoji, T, Mifune, Y, Kawamoto, A et al. (2011). Synergistic effect of adipose-derived stem cell therapy and bone marrow progenitor recruitment in ischemic heart. Lab Invest 91: 539-552
14. Bhang, SH, Cho, SW, La, WG, Lee, TJ, Yang, HS, Sun, AY et al. (2011). Angiogenesis in ischemic tissue produced by spheroid grafting of human adipose-derived stromal cells. Biomaterials 32: 2734-2747
15. Hoeben, A, Landuyt, B, Highley, MS, Wildiers, H, Van Oosterom, AT and De Bruijn, EA (2004). Vascular endothelial growth factor and angiogenesis. Pharmacol Rev 56: 549-580
16. Villaschi, S and Nicosia, RF (1993). Angiogenic role of endogenous basic fibroblast growth factor released by rat aorta after injury. Am J Pathol 143: 181-190
17. Morishita, R, Nakamura, S, Hayashi, S, Taniyama, Y, Moriguchi, A, Nagano, T et al. (1999). Therapeutic angiogenesis induced by human recombinant hepatocyte growth factor in rabbit hind limb ischemia model as cytokine supplement therapy. Hypertension 33: 1379-1384
18. Mirshahi, F, Pourtau, J, Li, H, Muraine, M, Trochon, V, Legrand, E et al. (2000). SDF-1 activity on microvascular endothelial cells: Consequences on angiogenesis in in vitro and in vivo models. Thromb Res 99: 587-594
19. Liakouli, V, Cipriani, P, Marrelli, A, Alvaro, S, Ruscitti, P and Giacomelli, R (2011). Angiogenic cytokines and growth factors in systemic sclerosis. Autoimmun Rev 10: 590-594
20. Marx, J (2003). Cancer research. Mutant stem cells may seed cancer. Science 301: 1308-1310
21. Stagg, J (2008). Mesenchymal stem cells in cancer. Stem Cell Rev 4: 119-124
22. Sell, S (2010). On the stem cell origin of cancer. Am J Pathol 176: 2584-2494
23. Land, SC and Rae, C (2005). iNOS initiates and sustains metabolic arrest in hypoxic lung adenocarcinoma cells: Mechanism of cell survival in solid tumor core. Am J Physiol Cell Physiol 289: C918-C933
24. Stein, I, Neeman, M, Shweiki, D, Itin, A and Keshet, E (1995). Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes. Mol Cell Biol 15: 5363-5368
25. Ikeda, E, Achen, MG, Breier, G and Risau, W (1995). Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells. J Biol Chem 270: 19761-19766
26. Sakaki, T, Yamada, K, Otsuki, H, Yuguchi, T, Kohmura, E and Hayakawa, T (1995). Brief exposure to hypoxia induces bFGF mRNA and protein and protects rat cortical neurons from prolonged hypoxic stress. Neurosci Res 23: 289-296
27. Kim, MS, Lee, CS, Hur, J, Cho, HJ, Jun, SI, Kim, TY et al. (2009). Priming with angiopoietin-1 augments the vasculogenic potential of the peripheral blood stem cells mobilized with granulocyte colony-stimulating factor through a novel Tie2/Ets-1 pathway. Circulation 120: 2240-2250
28. Leone, AM, Valgimigli, M, Giannico, MB, Zaccone, V, Perfetti, M, D'Amario, D et al. (2009). From bone marrow to the arterial wall: The ongoing tale of endothelial progenitor cells. Eur Heart J 30: 890-899
29. Lau, TT and Wang, DA (2011). Stromal cell-derived factor-1 (SDF-1): Homing factor for engineered regenerative medicine. Expert Opin Biol Ther 11: 189-197
30. Gerber, HP, Dixit, V and Ferrara, N (1998). Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells. J Biol Chem 273: 13313-13316
31. Nör, JE, Christensen, J, Mooney, DJ and Polverini, PJ (1999). Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression. Am J Pathol 154: 375-384
32. Chen, XH, Minatoguchi, S, Kosai, K, Yuge, K, Takahashi, T, Arai, M et al. (2007). In vivo hepatocyte growth factor gene transfer reduces myocardial ischemia-reperfusion injury through its multiple actions. J Card Fail 13: 874-883
33. Nakamura, T, Matsumoto, K, Mizuno, S, Sawa, Y, Matsuda, H and Nakamura, T (2005). Hepatocyte growth factor prevents tissue fibrosis, remodeling, and dysfunction in cardiomyopathic hamster hearts. Am J Physiol Heart Circ Physiol 288: H2131-H2139.